Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as a ...
The event is expected to draw 3,000 guests and features the reverse drawing for a Harley-Davidson motorcycle. Read more ...
Agencies have just one week to reclassify thousands of federal workers in purportedly policy-related roles into the new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results